Titre : Extrême-Orient

Extrême-Orient : Questions médicales fréquentes

Termes MeSH sélectionnés :

Retinal Detachment
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Extrême-Orient : Questions médicales les plus fréquentes", "headline": "Extrême-Orient : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Extrême-Orient : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-06", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Extrême-Orient" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Asie", "url": "https://questionsmedicales.fr/mesh/D001208", "about": { "@type": "MedicalCondition", "name": "Asie", "code": { "@type": "MedicalCode", "code": "D001208", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chine", "alternateName": "China", "url": "https://questionsmedicales.fr/mesh/D002681", "about": { "@type": "MedicalCondition", "name": "Chine", "code": { "@type": "MedicalCode", "code": "D002681", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hong Kong", "alternateName": "Hong Kong", "url": "https://questionsmedicales.fr/mesh/D006723", "about": { "@type": "MedicalCondition", "name": "Hong Kong", "code": { "@type": "MedicalCode", "code": "D006723", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164.450" } } }, { "@type": "MedicalWebPage", "name": "Tibet", "alternateName": "Tibet", "url": "https://questionsmedicales.fr/mesh/D018609", "about": { "@type": "MedicalCondition", "name": "Tibet", "code": { "@type": "MedicalCode", "code": "D018609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164.900" } } } ] }, { "@type": "MedicalWebPage", "name": "République démocratique populaire de Corée", "alternateName": "Democratic People's Republic of Korea", "url": "https://questionsmedicales.fr/mesh/D056911", "about": { "@type": "MedicalCondition", "name": "République démocratique populaire de Corée", "code": { "@type": "MedicalCode", "code": "D056911", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.557.500" } } }, { "@type": "MedicalWebPage", "name": "République de Corée", "alternateName": "Republic of Korea", "url": "https://questionsmedicales.fr/mesh/D056910", "about": { "@type": "MedicalCondition", "name": "République de Corée", "code": { "@type": "MedicalCode", "code": "D056910", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.557.750" } } }, { "@type": "MedicalWebPage", "name": "Mongolie", "alternateName": "Mongolia", "url": "https://questionsmedicales.fr/mesh/D008986", "about": { "@type": "MedicalCondition", "name": "Mongolie", "code": { "@type": "MedicalCode", "code": "D008986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.651" } } } ], "about": { "@type": "MedicalCondition", "name": "Extrême-Orient", "alternateName": "Asia, Eastern", "code": { "@type": "MedicalCode", "code": "D005202", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Masoud Dara", "url": "https://questionsmedicales.fr/author/Masoud%20Dara", "affiliation": { "@type": "Organization", "name": "WHO Regional Office for Europe, Copenhagen, Denmark. Electronic address: daram@who.int." } }, { "@type": "Person", "name": "Yakubu Egigogo Raji", "url": "https://questionsmedicales.fr/author/Yakubu%20Egigogo%20Raji", "affiliation": { "@type": "Organization", "name": "Department of Medical Microbiology Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "European Board and College of Obstetrics and Gynaecology (EBCOG), European Society of Contraception and Reproductive Health (ESCRH)." } }, { "@type": "Person", "name": "Tzung-Dau Wang", "url": "https://questionsmedicales.fr/author/Tzung-Dau%20Wang", "affiliation": { "@type": "Organization", "name": "Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan." } }, { "@type": "Person", "name": "Kazuomi Kario", "url": "https://questionsmedicales.fr/author/Kazuomi%20Kario", "affiliation": { "@type": "Organization", "name": "Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Retinal Detachment Present at Birth in an Infant With a Novel CTNNB1 Mutation.", "datePublished": "2022-07-01", "url": "https://questionsmedicales.fr/article/35858235", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3928/23258160-20220705-01" } }, { "@type": "ScholarlyArticle", "name": "The effect of sex and laterality on the phenotype of primary rhegmatogenous retinal detachment.", "datePublished": "2023-02-27", "url": "https://questionsmedicales.fr/article/36849827", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41433-023-02443-w" } }, { "@type": "ScholarlyArticle", "name": "Silicone oil residual after vitrectomy for rhegmatogenous retinal detachment.", "datePublished": "2022-09-20", "url": "https://questionsmedicales.fr/article/36127426", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41433-022-02210-3" } }, { "@type": "ScholarlyArticle", "name": "Clinical features of retinal detachment treated with segmental scleral buckling.", "datePublished": "2024-07-02", "url": "https://questionsmedicales.fr/article/38954136", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10792-024-03186-7" } }, { "@type": "ScholarlyArticle", "name": "Repair of a Tractional Retinal Detachment in the Setting of an Idiopathic Vasoproliferative Tumor.", "datePublished": "2023-08-01", "url": "https://questionsmedicales.fr/article/37535613", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3928/23258160-20230726-02" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Asie", "item": "https://questionsmedicales.fr/mesh/D001208" }, { "@type": "ListItem", "position": 4, "name": "Extrême-Orient", "item": "https://questionsmedicales.fr/mesh/D005202" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Extrême-Orient - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Extrême-Orient", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Extrême-Orient", "description": "Comment diagnostiquer une infection parasitaire en Extrême-Orient ?\nQuels examens pour le cancer du foie en Asie ?\nComment identifier une tuberculose en Extrême-Orient ?\nQuels tests pour le paludisme en Asie ?\nComment diagnostiquer une hépatite virale ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Retinal+Detachment&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Extrême-Orient", "description": "Quels sont les symptômes du choléra ?\nQuels signes d'une infection par le virus Nipah ?\nQuels symptômes de la dengue ?\nQuels symptômes de la grippe aviaire ?\nQuels signes d'une infection à Hantavirus ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Retinal+Detachment&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Extrême-Orient", "description": "Comment prévenir le choléra ?\nQuelles mesures pour éviter la dengue ?\nComment prévenir la tuberculose ?\nQuelles précautions pour le paludisme ?\nComment éviter l'hépatite A ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Retinal+Detachment&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Extrême-Orient", "description": "Quel traitement pour la tuberculose ?\nComment traiter le paludisme ?\nQuel traitement pour l'hépatite B ?\nComment traiter la dengue ?\nQuel traitement pour le choléra ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Retinal+Detachment&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Extrême-Orient", "description": "Quelles complications du choléra ?\nQuelles complications de la dengue ?\nQuelles complications de l'hépatite B ?\nQuelles complications de la tuberculose ?\nQuelles complications du paludisme ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Retinal+Detachment&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Extrême-Orient", "description": "Quels sont les facteurs de risque du choléra ?\nQuels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour l'hépatite A ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le paludisme ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Retinal+Detachment&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection parasitaire en Extrême-Orient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur des tests sanguins, des analyses de selles et des antécédents de voyage." } }, { "@type": "Question", "name": "Quels examens pour le cancer du foie en Asie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie, la tomodensitométrie et les tests de marqueurs tumoraux sont utilisés." } }, { "@type": "Question", "name": "Comment identifier une tuberculose en Extrême-Orient ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un test cutané, une radiographie pulmonaire et des cultures de crachats sont nécessaires." } }, { "@type": "Question", "name": "Quels tests pour le paludisme en Asie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques, comme le frottis sanguin, sont utilisés pour le diagnostic." } }, { "@type": "Question", "name": "Comment diagnostiquer une hépatite virale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins pour détecter les anticorps et les antigènes sont effectués." } }, { "@type": "Question", "name": "Quels sont les symptômes du choléra ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée aqueuse, vomissements et déshydratation rapide." } }, { "@type": "Question", "name": "Quels signes d'une infection par le virus Nipah ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, maux de tête, confusion et troubles respiratoires sont fréquents." } }, { "@type": "Question", "name": "Quels symptômes de la dengue ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs articulaires, éruptions cutanées et saignements peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes de la grippe aviaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, toux, difficultés respiratoires et douleurs musculaires sont typiques." } }, { "@type": "Question", "name": "Quels signes d'une infection à Hantavirus ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs abdominales, et symptômes respiratoires peuvent se manifester." } }, { "@type": "Question", "name": "Comment prévenir le choléra ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'accès à l'eau potable, l'hygiène et la vaccination sont cruciaux." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la dengue ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques sont efficaces." } }, { "@type": "Question", "name": "Comment prévenir la tuberculose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination BCG et le dépistage précoce des cas sont recommandés." } }, { "@type": "Question", "name": "Quelles précautions pour le paludisme ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires et des médicaments prophylactiques lors de voyages à risque." } }, { "@type": "Question", "name": "Comment éviter l'hépatite A ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains, consommer de l'eau potable et se faire vacciner sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour la tuberculose ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement standard inclut des antibiotiques sur plusieurs mois, comme l'isoniazide." } }, { "@type": "Question", "name": "Comment traiter le paludisme ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments antipaludiques comme la chloroquine ou l'artémisinine sont prescrits." } }, { "@type": "Question", "name": "Quel traitement pour l'hépatite B ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux comme le ténofovir et l'entécavir sont souvent utilisés." } }, { "@type": "Question", "name": "Comment traiter la dengue ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique ; la réhydratation et le soulagement des symptômes sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour le choléra ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La réhydratation orale ou intraveineuse et les antibiotiques sont essentiels." } }, { "@type": "Question", "name": "Quelles complications du choléra ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation sévère et le choc hypovolémique peuvent être mortels." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le syndrome de choc dengue et les hémorragies peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Quelles complications de l'hépatite B ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La cirrhose et le cancer du foie sont des complications possibles à long terme." } }, { "@type": "Question", "name": "Quelles complications de la tuberculose ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la fibrose pulmonaire et la dissémination à d'autres organes." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'anémie sévère, l'insuffisance rénale et le coma peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du choléra ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'accès limité à l'eau potable et une mauvaise hygiène augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la dengue ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones tropicales et avoir des moustiques à proximité sont des risques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour l'hépatite A ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des régions à risque et consommer des aliments contaminés augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la tuberculose ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "La malnutrition, le VIH et le surpeuplement sont des facteurs de risque majeurs." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le paludisme ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Vivre ou voyager dans des zones endémiques et ne pas utiliser de protection contre les moustiques." } } ] } ] }

Sources (6534 au total)

The effect of sex and laterality on the phenotype of primary rhegmatogenous retinal detachment.

To assess the effect of sex and laterality on clinical features of primary rhegmatogenous retinal detachment (RRD).... This study is a retrospective analysis of data prospectively collected. We extracted data from two online datasets over a 7-year period of patients older than 16 years who had undergone surgery for pr... Of 8133 eyes analyzed, 4342 (53.4%) were right. The overall male predominance (63.7%) was more marked in the age range 50-69 years. Men were more commonly pseudophakic and presented more frequently wi... This study confirmed the predominance of male sex and right laterality in RRD. Sex and laterality were associated with multiple presenting features of RRD including extent, break distribution, number,...

Silicone oil residual after vitrectomy for rhegmatogenous retinal detachment.

To explore the presence of residual emulsified silicone oil (SO) droplets in patients with rhegmatogenous retinal detachment (RRD) and their possible risk factors.... Patients who underwent primary pars plana vitrectomy with SO injection for RRD and SO removal at the same eye centre were included. Approximately 10 weeks after SO removal, B-scan ultrasonography was ... A total of 101 eyes were included. Residual SO particles were found in all the patients (100%), and the mean SOI was 4.04% ± 5.16% (range 0.06%-19.88%). Multiple linear regression revealed that, among... Patients with a larger AL and higher IOP before SO removal were more prone to have more residual SO droplets, which might in turn lead to an elevated IOP. In these eyes, thorough irrigation or repeate...

Clinical features of retinal detachment treated with segmental scleral buckling.

Our study aims to evaluate the surgical outcomes and clinical features of retinal detachment (RD) cases treated with segmental scleral buckling (SB), elucidating the role of segmental SB as a vital op... We retrospectively reviewed 128 eyes with primary rhegmatogenous RD that underwent segmental scleral buckling between November 2008 and December 2020. Clinical features and success rates were recorded... A total of 128 eyes were included. The patient's ages ranged from 12 to 72 years, with a median age of 45. Most of the eyes were phakic (97%). Regarding the type of break, 47% were holes, and flap tea... For phakic, low complexity retinal detachment in our study, segmental scleral buckling emerges as a surgical option with a high primary success rate and a lower incidence of complications....

Risk factors and prognostic factors associated with retinal detachment and visual outcomes in acute retinal necrosis.

To investigate the risk factors and prognostic factors that affect the long-term clinical outcomes of acute retinal necrosis (ARN).... A retrospective study of patients with ARN who underwent treatment and completed follow-up in our ophthalmology department from 2011 to 2021 was conducted. The incidence and risk factors of retinal de... Totally 59 ARN patients (65 eyes) with an average follow-up of 48.9 months were enrolled. During the follow-up period, RD occurred in 34 eyes (52.3%). The risk factors for RD included quadrants of inv... RD is a common and severe complication of ARN with multiple risk factors, such as initial retinitis involvement area and initial intraocular viral load. Active local antiviral therapy may reduce the r...

Surgical management of a case of giant retinal tear with closed funnel retinal detachment in a pediatric patient.

A 7-year-old male child was brought by his parents with a complaint of low vision in both eyes for 2 months. The child had low vision in both the eyes for 1.5 years, but the parents noticed when it wo... To educate regarding the surgical management of giant retinal tears in a pediatric patient.... To inform regarding the surgical challenges faced and steps adopted to manage such cases.... Through this case, we want to highlight the challenges faced, such as delayed presentation, difficult preoperative evaluation, intraoperative difficulties such as mobile retina, absence of posterior v... In such challenging situations, effective planning, careful manipulation, and persistence are essential for success.... https://youtu.be/T0Gy6Wj13zI....

Late Vitreoretinal Complications of Regressed Retinopathy of Prematurity: Retinal Break, Vitreous Hemorrhage, and Retinal Detachment.

To investigate late vitreoretinal complications and visual outcomes in patients with regressed retinopathy of prematurity (ROP) with or without prior treatment.... International, multicenter, noncomparative retrospective case series.... We analyzed 264 eyes of 238 patients from 13 centers worldwide who developed vitreoretinal complications (retinal detachment [RD], vitreous hemorrhage [VH], or retinal break) ≥ 2 years after resolutio... Each participant was assigned to 1 of 3 groups (the RD, VH, and retinal break groups) according to their primary diagnosis. The average age at presentation, visual acuities, refractive error, axial le... Clinical features and visual outcomes of late vitreoretinal complications in patients with regressed ROP.... A total of 264 eyes of 238 patients were included. The prior acute ROP status was comparable among the 3 groups, except that the VH group had a higher proportion of patients with type 1 ROP (P = 0.03)... Infants with acute ROP remain at a high risk of vision-threatening complications throughout childhood and adulthood. Continual follow-up of patients with ROP is important. When severe complications, s...

Tractional Retinal Detachment in Eyes with Vitreous Hemorrhage and Proliferative Diabetic Retinopathy and Posterior Vitreous Detachment in Fellow Eye.

To predict the presence of tractional retinal detachment (TRD) in eyes with dense vitreous hemorrhage (VH) and proliferative diabetic retinopathy (PDR) by evaluating the status of posterior vitreous d... A total of 44 eyes from 22 patients who underwent vitrectomy due to dense VH with PDR were enrolled. Using OCT, the PVD status in the fellow eye was divided into two groups (incomplete and complete PV... There was a difference in the interobserver agreement regarding the presence of TRD in eyes with dense VH evaluated by B scan between novice and experienced ophthalmologists (novice, κ = 0.421 vs. exp... Evaluation of the PVD status in the fellow eye using OCT may be a useful predictor for detecting the presence of TRD in eyes with dense VH and PDR....

Stratifying the risk of re-detachment: variables associated with outcome of vitrectomy for rhegmatogenous retinal detachment in a large UK cohort study.

To identify variables associated with primary anatomical outcome following vitrectomy and internal tamponade for rhegmatogenous retinal detachment (RD).... A retrospective analysis of prospectively collected data, using a database of RD treated with vitrectomy and internal tamponade. Collected data complied with the RCOphth Retinal Detachment Dataset. Th... There were 6377 vitrectomies. 869 eyes were excluded, either because no outcome was recorded, or inadequate follow up, leaving 5508 operations for analysis. 63.9% of patients were male, and the median... Previous attempts to identify high risk RD have been limited by small numbers, the inclusion of both scleral buckling and vitrectomy, or by excluding some types of RD. This study examined outcomes in ...